Siemens Healthineers AG Stock Deutsche Boerse AG

Equities

SHL

DE000SHL1006

Advanced Medical Equipment & Technology

Market Closed - Deutsche Boerse AG 11:08:44 2024-06-28 EDT 5-day change 1st Jan Change
53.84 EUR -2.36% Intraday chart for Siemens Healthineers AG +1.55% +1.39%

Financials

Sales 2024 * 22.67B 24.29B 33.21B Sales 2025 * 24.25B 25.97B 35.52B Capitalization 60.03B 64.3B 87.93B
Net income 2024 * 2.02B 2.16B 2.95B Net income 2025 * 2.56B 2.74B 3.74B EV / Sales 2024 * 3.17 x
Net Debt 2024 * 11.87B 12.72B 17.39B Net Debt 2025 * 10.53B 11.27B 15.42B EV / Sales 2025 * 2.91 x
P/E ratio 2024 *
29.9 x
P/E ratio 2025 *
23.6 x
Employees 71,000
Yield 2024 *
1.9%
Yield 2025 *
2.31%
Free-Float 23.81%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.36%
1 week+1.55%
Current month+0.52%
1 month-0.70%
3 months-4.81%
6 months+1.47%
Current year+1.39%
More quotes
1 week
52.82
Extreme 52.82
55.50
1 month
52.04
Extreme 52.04
55.50
Current year
49.85
Extreme 49.85
58.16
1 year
44.46
Extreme 44.46
58.16
3 years
40.53
Extreme 40.53
67.88
5 years
28.51
Extreme 28.505
67.88
10 years
28.51
Extreme 28.505
67.88
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 17-12-31
Director of Finance/CFO 57 17-12-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 64 22-10-31
Director/Board Member 57 21-03-22
Director/Board Member 72 18-02-28
More insiders
Date Price Change Volume
24-06-28 53.84 -2.36% 2,488
24-06-27 55.14 +1.40% 10,654
24-06-26 54.38 +1.15% 300
24-06-25 53.76 +0.30% 26
24-06-24 53.6 +1.09% 432

Delayed Quote Deutsche Boerse AG, June 28, 2024 at 11:08 am

More quotes
Siemens Healthineers AG is one of the world's No.1 manufacturers of equipment for medical imaging, laboratory diagnostics and hospital information systems. In addition, the group is developing digital health services and services dedicated to health establishments. Net sales break down by activity as follows: - sale of imaging equipment and solutions (53%); - sale of diagnostic equipment (21%); - sale of solutions and services for cancer care (16.6%); - sale of advanced therapeutic solutions (9.4%): for image-guided minimally invasive treatments in the areas of cardiology, interventional radiology and surgery. Net sales are distributed geographically as follows: Germany (4.9%), Europe/CIS/Africa/Middle East (27.3%), the United States (34.6%), America (6.3%), China (13%) and Asia/Pacific and Japan (13.9%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
53.8 EUR
Average target price
60.62 EUR
Spread / Average Target
+12.67%
Consensus